DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
PH-797804 is an investigational drug.
There have been 14 clinical trials for PH-797804. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2008.
The most common disease conditions in clinical trials are Lung Diseases, Pulmonary Disease, Chronic Obstructive, and Lung Diseases, Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for PH-797804
|A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804||Pfizer||Phase 1|
|A Study to Investigate the Effect of PH-797804 on QTc Interval||Pfizer||Phase 1|
|A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804||Pfizer||Phase 1|